John R. Glass serves as Executive at PROVECTUS BIOPHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, John R. Glass has executed 2 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 14, 2017 involved purchasing 115,900 shares valued at $5.8K.
John R. Glass currently holds 200,000 shares of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John R. Glass has been a net buyer of PVCT stock. They have purchased $10.0K and sold $0 worth of shares.
John R. Glass's most recent insider trade was on Dec 14, 2017, when they purchased 115,900 shares at $0.05 per share.
Get notified when new Form 4 filings are submitted
| $0.05 |
| Discretionary |